Cargando…

Editorial: The heart of NAFLD

Detalles Bibliográficos
Autores principales:	Chew, Nicholas W. S., Kannan, Shankar, Chong, Bryan, Chin, Yiphan, Muthiah, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240047/ https://www.ncbi.nlm.nih.gov/pubmed/37283629 http://dx.doi.org/10.3389/fmed.2023.1209625

Ejemplares similares

Editorial: New Insights Into Understanding and Managing NAFLD
por: Escribano, Óscar, et al.
Publicado: (2021)

A poor perspective of self weight significantly increases adverse outcomes in non-alcoholic fatty liver disease (NAFLD)
por: Fu, Clarissa Elysia, et al.
Publicado: (2022)

Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
por: Zhang, Chunye, et al.
Publicado: (2021)

General Public’s knowledge, awareness, and perception of Cardiometabolic diseases: data from a Singapore study population
por: Anand, Vickram Vijay, et al.
Publicado: (2023)

Editorial: The NAFLD-MAFLD conundrum
por: Dalbeni, Andrea, et al.
Publicado: (2023)

COVID-19 and MAFLD/NAFLD: An updated review
por: Nowroozi, Ali, et al.
Publicado: (2023)

Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis
por: Garcia-Martinez, Irma, et al.
Publicado: (2020)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Editorial: Novel Risk Predicting System for Heart Failure
por: Liu, Chen, et al.
Publicado: (2022)

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
por: Marques, Vanda, et al.
Publicado: (2021)

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials
por: Hegazi, Omar E., et al.
Publicado: (2023)

A continuous-time Markov chain model of fibrosis progression in NAFLD and NASH
por: Meyer, Lyndsey F., et al.
Publicado: (2023)

Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 Individuals
por: Nah, Benjamin Kai Yi, et al.
Publicado: (2022)

Editorial: Non-coding RNAs in heart failure
por: Booz, George W., et al.
Publicado: (2022)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population
por: Shaheen, Magda, et al.
Publicado: (2021)

Editorial: Foods and Macronutrients in NAFLD: Associations, Effects and Mechanisms
por: Rosqvist, Fredrik, et al.
Publicado: (2021)

Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
por: Abu-Farha, Mohamed, et al.
Publicado: (2022)

Editorial: Women in heart valve disease
por: Veulemans, Verena, et al.
Publicado: (2023)

Editorial: Insights in heart surgery: 2022
por: Bonacchi, Massimo, et al.
Publicado: (2023)

Editorial: Aortopathy in congenital heart disease
por: Weismann, Constance G., et al.
Publicado: (2023)

Editorial: Advanced echocardiographic techniques in structural heart intervention
por: Wong, Randolph H. L., et al.
Publicado: (2022)

Editorial: The heterogeneity in COPD phenotypes
por: Tanabe, Naoya, et al.
Publicado: (2022)

Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation
por: Xu, Zijin, et al.
Publicado: (2021)

Age and Interleukin-15 Levels Are Independently Associated With Intima-Media Thickness in Obesity-Related NAFLD Patients
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Editorial: Novel and emerging therapies in heart failure
por: Giamouzis, Grigorios, et al.
Publicado: (2023)

Editorial: Insights in heart failure and transplantation: 2022
por: Cameli, Matteo, et al.
Publicado: (2023)

Editorial: The Role of Sex in Heart Failure and Transplantation
por: Martínez-Sellés, Manuel, et al.
Publicado: (2021)

Editorial: Multimodality Imaging in Valvular Heart Disease
por: Treibel, Thomas A., et al.
Publicado: (2021)

Editorial: Highlights in Heart Failure and Transplantation in 2021
por: Cameli, Matteo, et al.
Publicado: (2022)

Editorial: Highlights in heart valve disease: 2021
por: Elena, Aikawa
Publicado: (2022)

Editorial: Insight in heart valve disease: 2021
por: Iop, Laura, et al.
Publicado: (2022)

Editorial: Mitochondrial Metabolism in Ischemic Heart Disease
por: Yang, Lei, et al.
Publicado: (2022)

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD
por: Xiong, Xuelian
Publicado: (2023)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

DEXA Scan Body Fat Mass Distribution in Obese and Non-Obese Individuals and Risk of NAFLD—Analysis of 10,865 Individuals
por: Tan, Caitlyn, et al.
Publicado: (2022)

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
por: Chew, Nicholas W.S., et al.
Publicado: (2022)

The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies
por: Quek, Jingxuan, et al.
Publicado: (2021)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Editorial: New insights in heart valve disease 2022
por: Greco, Ernesto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jf9a1u25sq282trmdg4ju0fvcg